Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Diphenhydramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for diphenhydramine hydrochloride?

Diphenhydramine hydrochloride is the generic ingredient in sixteen branded drugs marketed by Whiteworth Town Plsn, Elkins Sinn, Pioneer Pharms, Cenci, Alpharma Us Pharms, Mutual Pharm, Impax Labs, Cumberland Swan, Pharm Assoc, Halsey, Parke Davis, Hi Tech Pharma, West-ward Pharms Int, Morton Grove, Alra, Kv Pharm, Bel Mar, Heather, Warner Chilcott, Fresenius Kabi Usa, Pvt Form, Watson Labs, Vangard, Sandoz, Nexgen Pharma Inc, Roxane, Lederle, Purepac Pharm, Barr, Lannett, Superpharm, Usl Pharma, Hospira, Newtron Pharms, Mcneil Cons, Silarx, Perrigo, Ivax Sub Teva Pharms, App Pharms, Lyphomed, Hikma Intl Pharms, Watson Labs Inc, Teva, Bundy, Anabolic, LNK, Wyeth Ayerst, Naska, Eurohlth Intl Sarl, Abraxis Pharm, Mk Labs, Sun Pharm Inds, Valeant Pharm Intl, Intl Medication, Mylan Institutional, Strides Pharma, Pfizer, Bionpharma Inc, and Bayer Hlthcare, and is included in ninety-two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for diphenhydramine hydrochloride. Seventeen suppliers are listed for this compound.

Summary for Generic Name: diphenhydramine hydrochloride

Drug Master File Entries: see list23
Suppliers / Packagers: see list17
Bulk Api Vendors: see list56
Clinical Trials: see list1,072
Patent Applications: see list9,882
Therapeutic Class:Antiemetics
Antiparkinson Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diphenhydramine hydrochloride at DailyMed

Pharmacology for Ingredient: diphenhydramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
diphenhydramine hydrochloride
ELIXIR;ORAL087941-001Dec 17, 1982DISCNNoNo► Subscribe► Subscribe
diphenhydramine hydrochloride
CAPSULE;ORAL084524-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
diphenhydramine hydrochloride
CAPSULE;ORAL083797-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
diphenhydramine hydrochloride
CAPSULE;ORAL083953-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Valeant Pharm Intl
diphenhydramine hydrochloride
CAPSULE;ORAL080592-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.